{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T19:11:30Z","timestamp":1786821090355,"version":"build-2736575974"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Lower urinary tract symptoms (LUTS) involve benign prostatic hyperplasia (BPH) and overactive bladder (OAB). Standard-of-care medical treatment includes \u03b1<jats:sub>1<\/jats:sub>-blockers and antimuscarinics for reduction of prostate and detrusor smooth muscle tone, respectively, and 5\u03b1-reductase inhibitors (5-ARI) to prevent prostate growth. Current medications are marked by high discontinuation rates due to unfavourable balance between efficacy and treatment-limiting side effects, ranging from dry mouth for antimuscarinics to cardiovascular dysregulation and a tendency to fall for \u03b1<jats:sub>1<\/jats:sub>-blockers, which results from hypotension, due to vasorelaxation. Agonist-induced smooth muscle contractions are caused by activation of receptor-coupled G-proteins. However, little is known about receptor- and organ-specific differences in coupling to G-proteins. With YM-254890, a small molecule inhibitor with presumed specificity for G\u03b1<jats:sub>q\/11<\/jats:sub> became recently available. Here, we investigated effects of YM-254890 on prostate, bladder and vascular smooth muscle contraction, and on growth-related functions in prostate stromal cells.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Contractions of human prostate and detrusor tissues, porcine renal and coronary arteries were induced in an organ bath. Proliferation (EdU assay), growth (colony formation), apoptosis and cell death (flow cytometry), viability (CCK-8) and actin organization (phalloidin staining) were studied in cultured human prostate stromal cells (WPMY-1).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Contractions by \u03b1<jats:sub>1<\/jats:sub>-adrenergic agonists, U46619, endothelin-1, and neurogenic contractions were nearly completely inhibited by YM-254890 (30\u00a0nM) in prostate tissues. Contractions by cholinergic agonists, U46619, endothelin-1, and neurogenic contractions were only partly inhibited in detrusor tissues. Contractions by \u03b1<jats:sub>1<\/jats:sub>-adrenergic agonists, U46619, endothelin-1, and neurogenic contractions were strongly, but not fully inhibited in renal arteries. Contractions by cholinergic agonists were completely, but by U46619 and endothelin-1 only strongly inhibited, and neurogenic contractions reduced by half in coronary arteries. YM-254890 had no effect on agonist-independent contractions induced by highmolar (80\u00a0mM) potassium chloride (KCl). Neurogenic detrusor contractions were fully sensitive to tetrodotoxin. In WPMY-1 cells, YM-254890 caused breakdown of actin polymerization and organization, and obvious, but clearly limited decreases of proliferation rate, colony formation and viability, and slightly increased apoptosis.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Intracellular post-receptor signaling pathways are shared by G\u03b1<jats:sub>q<\/jats:sub>-coupled contractile receptors in multiple smooth muscle-rich organs, but to different extent. While inhibition of G\u03b1<jats:sub>q\/11<\/jats:sub> causes actin breakdown, anti-proliferative effects were detectable but clearly limited. Together this may aid in developing future pharmaceutical targets for LUTS and antihypertensive medication.<\/jats:p>","DOI":"10.3389\/fphys.2022.884057","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T07:43:15Z","timestamp":1653291795000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule G\u03b1q\/11 Inhibitor, YM-254890"],"prefix":"10.3389","volume":"13","author":[{"given":"Alexander","family":"Tamalunas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ciotkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Rutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ledderose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Magistro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hennenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.eururo.2014.02.012","article-title":"Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-Blind, Dose-Ranging, Phase 2 Study (Symphony)","volume":"67","author":"Abrams","year":"2015","journal-title":"Eur. Urol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.eururo.2008.11.011","article-title":"Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review","volume":"55","author":"Alcaraz","year":"2009","journal-title":"Eur. Urol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1111\/bph.15538","article-title":"THE CONCISE GUIDE TO PHARMACOLOGY 2021\/22: G Protein-Coupled Receptors","author":"Alexander","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.semcdb.2015.12.015","article-title":"Feedback Regulation of G Protein-Coupled Receptor Signaling by GRKs and Arrestins","volume":"50","author":"Black","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(21)00221-X","article-title":"Arterial Hypertension","volume":"398","author":"Brouwers","year":"2021","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00210-013-0935-3","article-title":"Pharmacological Characterization of N1-(2-Methoxyphenyl)-N4-Hexylpiperazine as a Multi-Target Antagonist of alpha1A\/alpha1D-Adrenoceptors and 5-HT1A Receptors that Blocks Prostate Contraction and Cell Growth","volume":"387","author":"Chagas-Silva","year":"2014","journal-title":"Schmiedeb. Arch. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-16499-6_1","article-title":"Overview on the Lower Urinary Tract","volume":"2011","author":"Chapple","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on Diabetes, Pre-diabetes, and Cardiovascular Diseases Developed in Collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur. Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1111\/bph.12856","article-title":"Experimental Design and Analysis and Their Reporting: New Guidance for Publication in BJP","volume":"172","author":"Curtis","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental Design and Analysis and Their Reporting II: Updated and Simplified Guidance for Authors and Peer Reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.eururo.2016.09.032","article-title":"Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis","volume":"71","author":"Dahm","year":"2017","journal-title":"Eur. Urol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coph.2014.03.003","article-title":"The Pharmacological Rationale for Combining Muscarinic Receptor Antagonists and \u03b2-adrenoceptor Agonists in the Treatment of Airway and Bladder Disease","volume":"16","author":"Dale","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","article-title":"Pathophysiology of Diabetic Kidney Disease: Impact of SGLT2 Inhibitors","volume":"17","author":"DeFronzo","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00210-019-01727-x","article-title":"Normalization of Organ Bath Contraction Data for Tissue Specimen Size: Does One Approach Fit All?","volume":"393","author":"Erdogan","year":"2020","journal-title":"Schmiedeb. Arch. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00210-007-0208-0","article-title":"Signal Transduction Underlying the Control of Urinary Bladder Smooth Muscle Tone by Muscarinic Receptors and \u03b2-adrenoceptors","volume":"377","author":"Frazier","year":"2008","journal-title":"Naunyn-Schmied Arch. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/nau.23554","article-title":"Alpha-1 Adrenergic Antagonists, 5-alpha Reductase Inhibitors, Phosphodiesterase Type 5 Inhibitors, and Phytotherapic Compounds in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: A Systematic Review and Meta-Analysis of Urodynamic Studies","volume":"37","author":"Fusco","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/1097-0045(200101)46:1<45::aid-pros1007>3.0.co;2-u","article-title":"Combined Effect of Terazosin and Finasteride on Apoptosis, Cell Proliferation, and Transforming Growth Factor-Beta Expression in Benign Prostatic Hyperplasia","volume":"46","author":"Glassman","year":"2001","journal-title":"Prostate"},{"key":"B18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/01.res.87.3.221","article-title":"Role for G(12)\/G(13) in Agonist-Induced Vascular Smooth Muscle Cell Contraction","volume":"87","author":"Gohla","year":"2000","journal-title":"Circulation Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/(sici)1097-0045(19980215)34:3<214::aid-pros9>3.0.co;2-h","article-title":"Induction of Atypical Prostatic Hyperplasia in Rats by Sympathomimetic Stimulation","volume":"34","author":"Golomb","year":"1998","journal-title":"Prostate"},{"key":"B20","article-title":"Management of Non-neurogenic Male LUTS","author":"Gravas","year":"2021"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/nau.22467","article-title":"Prostatic Alpha1-Adrenoceptors: New Concepts of Function, Regulation, and Intracellular Signaling","volume":"33","author":"Hennenberg","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"B22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/pros.10267","article-title":"Norepinephrine Activates P44 and P42 MAPK in Human Prostate Stromal and Smooth Muscle Cells but Not in Epithelial Cells","volume":"56","author":"Kanagawa","year":"2003","journal-title":"Prostate"},{"key":"B23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/ndt\/gfn583","article-title":"Myogenic Tone and Small Artery Remodelling: Insight into Diabetic Nephropathy","volume":"24","author":"Khavandi","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"F823","DOI":"10.1152\/ajprenal.00011.2014","article-title":"Inhibition of Smooth Muscle Force Generation by Focal Adhesion Kinase Inhibitors in the Hyperplastic Human Prostate","volume":"307","author":"Kunit","year":"2014","journal-title":"Am. J. Physiol.-Renal Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1097\/00005392-199806000-00005","article-title":"Induction of Prostate Apoptosis by Doxazosin in Benign Prostatic Hyperplasia","volume":"159","author":"Kyprianou","year":"1998","journal-title":"J. Urol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/1097-0045(2000)45:9+<42::aid-pros9>3.0.co;2-u","article-title":"Effects of Alpha(1)-Adrenoceptor (alpha(1)-AR) Antagonists on Cell Proliferation and Apoptosis in the Prostate: Therapeutic Implications in Prostatic Disease","volume":"45","author":"Kyprianou","year":"2000","journal-title":"Prostate"},{"key":"B27","first-page":"S3","article-title":"Pathophysiology, Epidemiology, and Natural History of Benign Prostatic Hyperplasia","author":"Lepor","year":"2004","journal-title":"Rev. Urol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e00771","DOI":"10.1002\/prp2.771","article-title":"Picotamide Inhibits a Wide Spectrum of Agonist\u2010induced Smooth Muscle Contractions in Porcine Renal Interlobar and Coronary Arteries","volume":"9","author":"Li","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"B29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11892-021-01387-3","article-title":"The Prevalence of Diabetic Microvascular Complications in China and the USA","volume":"21","author":"Lin","year":"2021","journal-title":"Curr. Diab Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0140-6736(20)31287-3","article-title":"Surgery for Benign Prostatic Obstruction","volume":"396","author":"Magistro","year":"2020","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/pros.10170","article-title":"Mechanistic Investigation of the Adrenergic Induction of Ventral Prostate Hyperplasia in Mice","volume":"54","author":"Marinese","year":"2003","journal-title":"Prostate"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1478-811X-2-5","article-title":"Mitogen Activated Protein Kinase Signal Transduction Pathways in the Prostate","volume":"2","author":"Maroni","year":"2004","journal-title":"Cell Commun. Signal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/s0094-0143(21)00961-7","article-title":"Pathology of Benign Prostatic Hyperplasia","volume":"17","author":"McNeal","year":"1990","journal-title":"Urol. Clin. N. Am."},{"key":"B34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1095\/biolreprod51.1.99","article-title":"Growth of the Rat Prostate Gland Is Facilitated by the Autonomic Nervous System","volume":"51","author":"McVary","year":"1994","journal-title":"Biol. Reprod."},{"key":"B35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/sj.pcan.4500267","article-title":"Comparison of Tamsulosin Efficacy in Subgroups of Patients with Lower Urinary Tract Symptoms","volume":"1","author":"Michel","year":"1998","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/mol.119.118927","article-title":"New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology","volume":"97","author":"Michel","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCRESAHA.111.248898","article-title":"p63RhoGEF Couples Galpha(q\/11)-Mediated Signaling to Ca2+ Sensitization of Vascular Smooth Muscle Contractility","volume":"109","author":"Momotani","year":"2011","journal-title":"Circ. Res."},{"key":"B38","first-page":"2857","article-title":"Adrenergic Control of Coronary Arteries","volume":"43","author":"Moreland","year":"1984","journal-title":"Fed. Proc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.eururo.2017.12.031","article-title":"EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence","volume":"73","author":"Nambiar","year":"2018","journal-title":"Eur. Urol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"117048","DOI":"10.1016\/j.lfs.2019.117048","article-title":"The \u03b11-adrenoceptor-mediated Human Hyperplastic Prostate Cells Proliferation Is Impaired by EGF Receptor Inhibition","volume":"239","author":"Nascimento-Viana","year":"2019","journal-title":"Life Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinthera.2007.01.018","article-title":"A Review of the Clinical Efficacy and Safety of 5\u03b1-Reductase Inhibitors for the Enlarged Prostate","volume":"29","author":"Naslund","year":"2007","journal-title":"Clin. Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"13666","DOI":"10.1073\/pnas.1003553107","article-title":"Structural Basis for the Specific Inhibition of Heterotrimeric G Q Protein by a Small Molecule","volume":"107","author":"Nishimura","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00120-009-2141-y","article-title":"Medikament\u00f6se Therapie der benignen Prostatahyperplasie","volume":"48","author":"Oelke","year":"2009","journal-title":"Urologe"},{"key":"B44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"EAU Guidelines on the Treatment and Follow-Up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction","volume":"64","author":"Oelke","year":"2013","journal-title":"Eur. Urol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1073\/pnas.91.2.504","article-title":"G Proteins of the G12 Family Are Activated via Thromboxane A2 and Thrombin Receptors in Human Platelets","volume":"91","author":"Offermanns","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrurol.2012.192","article-title":"The Link between Benign Prostatic Hyperplasia and Prostate Cancer","volume":"10","author":"Orsted","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/ncpuro1060","article-title":"Medical Management of Lower Urinary Tract Symptoms in Men: Current Treatment and Future Approaches","volume":"5","author":"Patel","year":"2008","journal-title":"Nat. Rev. Urol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1021\/jm9705115","article-title":"6\u03b2-Acetoxynortropane: A Potent Muscarinic Agonist with Apparent Selectivity toward M2-Receptors","volume":"41","author":"Pei","year":"1998","journal-title":"J. Med. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"173706","DOI":"10.1016\/j.ejphar.2020.173706","article-title":"Functional Evidence for Biased Inhibition of G Protein Signaling by YM-254890 in Human Coronary Artery Endothelial Cells","volume":"891","author":"Peng","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"841181","DOI":"10.3389\/fphys.2022.841181","article-title":"The Dependence of Urinary Bladder Responses on Extracellular Calcium Varies between Muscarinic, Histamine, 5-HT (Serotonin), Neurokinin, Prostaglandin, and Angiotensin Receptor Activation","volume":"13","author":"Phelps","year":"2022","journal-title":"Front. Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-3-642-16499-6_7","article-title":"Anatomy and Histology of the Lower Urinary Tract","volume":"2011","author":"Pradidarcheep","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1084\/jem.103.5.653","article-title":"Action of X-Rays on Mammalian Cells","volume":"103","author":"Puck","year":"1956","journal-title":"J. Exp. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.3791\/2573","article-title":"Clonogenic Assay: Adherent Cells","volume":"2011","author":"Rafehi","year":"2011","journal-title":"JoVE"},{"key":"B54","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.juro.2007.09.084","article-title":"The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-year Results from the CombAT Study","volume":"179","author":"Roehrborn","year":"2008","journal-title":"J. Urol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-year Results from the CombAT Study","volume":"57","author":"Roehrborn","year":"2010","journal-title":"Eur. Urol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/sj.pcan.4500849","article-title":"Three Months' Treatment with the \u03b11-Blocker Alfuzosin Does Not Affect Total or Transition Zone Volume of the Prostate","volume":"9","author":"Roehrborn","year":"2006","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"C571","DOI":"10.1152\/ajpcell.2001.281.2.C571","article-title":"Rho Activation in Excitatory Agonist-Stimulated Vascular Smooth Muscle","volume":"281","author":"Sakurada","year":"2001","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/path.2077","article-title":"The Ageing Male Reproductive Tract","volume":"211","author":"Sampson","year":"2007","journal-title":"J. Pathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1742-1241.2010.02626.x","article-title":"Persistence and Adherence in the Treatment of Overactive Bladder Syndrome with Anticholinergic Therapy: a Systematic Review of the Literature","volume":"65","author":"Sexton","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"B61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3892\/mmr.2011.647","article-title":"The Peripheral Zone of the Prostate Is More Prone to Tumor Development Than the Transitional Zone: Is the ETS Family the Key?","volume":"5","author":"Shaikhibrahim","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1469-7793.2000.t01-2-00177.x","article-title":"Signal Transduction by G\u2010proteins, Rho\u2010kinase and Protein Phosphatase to Smooth Muscle and Non\u2010muscle Myosin II","volume":"522","author":"Somlyo","year":"2000","journal-title":"J. Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00210-020-02044-4","article-title":"Purinergic Smooth Muscle Contractions in the Human Prostate: Estimation of Relevance and Characterization of Different Agonists","volume":"394","author":"Spek","year":"2021","journal-title":"Schmiedeb. Arch. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"47438","DOI":"10.1074\/jbc.M408846200","article-title":"A Novel G\u03b1q\/11-Selective Inhibitor","volume":"279","author":"Takasaki","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5173\/ceju.2021.130","article-title":"The Impact of Preoperative Lower Urinary Tract Symptoms Medication on the Functional Performance of Holmium Laser Enucleation of the Prostate","volume":"74","author":"Tamalunas","year":"2021","journal-title":"Cent. Eur. J. Urol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"358","DOI":"10.7164\/antibiotics.56.358","article-title":"YM-254890, a Novel Platelet Aggregation Inhibitor Produced by Chromobacterium Sp. QS3666","volume":"56","author":"Taniguchi","year":"2003","journal-title":"J. Antibiot."},{"key":"B68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.diff.2011.08.002","article-title":"Prostate Development and Growth in Benign Prostatic Hyperplasia","volume":"82","author":"Timms","year":"2011","journal-title":"Differentiation"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/carcin\/20.7.1185","article-title":"A Human Prostatic Stromal Myofibroblast Cell Line WPMY-1: a Model for Stromal-Epithelial Interactions in Prostatic Neoplasia","volume":"20","author":"Webber","year":"1999","journal-title":"Carcinogenesis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global Epidemiology, Health Burden and Effective Interventions for Elevated Blood Pressure and Hypertension","volume":"18","author":"Zhou","year":"2021","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.884057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T07:43:19Z","timestamp":1653291799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.884057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":69,"alternative-id":["10.3389\/fphys.2022.884057"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.884057","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"article-number":"884057"}}